Alphabet’s health division, Verily, has received FDA 510(k) clearance for its Study smart watch for an “on-demand ECG feature.” The Study Watch, announced in April 2017, is not a consumer smartwatch, but instead meant as a test platform for the Google-adjacent company to research how to best gather health data on a wearable.
Back when it was announced, Verily said that it had an ECG feature alongside the usual stuff you expect on a smartwatch — but it didn’t receive clearance from the FDA for it until today (oddly, in the midst of a government shutdown).
When Apple announced its electrocardiogram feature for the Apple Watch, it seemed like a completely unique and differentiating feature. Now, it’s starting to feel like EKG is about to…
from The Verge – All Posts http://bit.ly/2MjSuOr
via IFTTT